1. Home
  2. HTCR vs MRKR Comparison

HTCR vs MRKR Comparison

Compare HTCR & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTCR
  • MRKR
  • Stock Information
  • Founded
  • HTCR 2009
  • MRKR N/A
  • Country
  • HTCR Japan
  • MRKR United States
  • Employees
  • HTCR N/A
  • MRKR N/A
  • Industry
  • HTCR EDP Services
  • MRKR Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTCR Technology
  • MRKR Health Care
  • Exchange
  • HTCR Nasdaq
  • MRKR Nasdaq
  • Market Cap
  • HTCR 13.6M
  • MRKR 11.8M
  • IPO Year
  • HTCR 2022
  • MRKR N/A
  • Fundamental
  • Price
  • HTCR $0.60
  • MRKR $1.24
  • Analyst Decision
  • HTCR
  • MRKR Strong Buy
  • Analyst Count
  • HTCR 0
  • MRKR 3
  • Target Price
  • HTCR N/A
  • MRKR $13.17
  • AVG Volume (30 Days)
  • HTCR 45.3K
  • MRKR 38.3K
  • Earning Date
  • HTCR 05-20-2025
  • MRKR 05-19-2025
  • Dividend Yield
  • HTCR 3.51%
  • MRKR N/A
  • EPS Growth
  • HTCR N/A
  • MRKR N/A
  • EPS
  • HTCR N/A
  • MRKR N/A
  • Revenue
  • HTCR $30,407,229.00
  • MRKR $6,591,080.00
  • Revenue This Year
  • HTCR N/A
  • MRKR N/A
  • Revenue Next Year
  • HTCR N/A
  • MRKR N/A
  • P/E Ratio
  • HTCR N/A
  • MRKR N/A
  • Revenue Growth
  • HTCR 39.19
  • MRKR 99.06
  • 52 Week Low
  • HTCR $0.52
  • MRKR $0.95
  • 52 Week High
  • HTCR $3.38
  • MRKR $5.99
  • Technical
  • Relative Strength Index (RSI)
  • HTCR 36.41
  • MRKR 50.23
  • Support Level
  • HTCR $0.53
  • MRKR $1.10
  • Resistance Level
  • HTCR $0.61
  • MRKR $1.29
  • Average True Range (ATR)
  • HTCR 0.04
  • MRKR 0.08
  • MACD
  • HTCR 0.01
  • MRKR 0.01
  • Stochastic Oscillator
  • HTCR 33.77
  • MRKR 58.10

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: